Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 14,886,000 | 14,342,000 | 13,959,000 | 13,010,000 | 13,858,000 |
Cost of Goods | 4,320,000 | 4,390,000 | 4,523,000 | 4,213,000 | 4,684,000 |
Gross Profit | 10,566,000 | 9,952,000 | 9,436,000 | 8,797,000 | 9,174,000 |
Operating Expenses | 5,492,000 | 5,646,000 | 4,995,000 | 4,694,000 | 5,421,000 |
Operating Income | 5,074,000 | 4,306,000 | 4,441,000 | 4,103,000 | 3,753,000 |
Interest Expense | 571,000 | 585,000 | 606,000 | 622,000 | 618,000 |
Other Income | -232,000 | -33,000 | -2,672,000 | 386,000 | -4,642,000 |
Pre-tax Income | 4,271,000 | 3,688,000 | 1,163,000 | 3,867,000 | -1,507,000 |
Income Tax | 226,000 | 508,000 | 394,000 | 312,000 | -1,545,000 |
Net Income Continuous | 4,045,000 | 3,180,000 | 769,000 | 3,555,000 | 38,000 |
Minority Interests | 1,000 | 1,000 | 3,000 | 2,000 | 2,000 |
Net Income | $4,044,000 | $3,179,000 | $766,000 | $3,553,000 | $36,000 |
EPS Basic Total Ops | 2.28 | 1.78 | 0.42 | 2.00 | -0.13 |
EPS Basic Continuous Ops | 2.28 | 1.80 | 0.43 | 2.01 | -0.12 |
EPS Diluted Total Ops | 2.26 | 1.78 | 0.42 | 1.99 | -0.13 |
EPS Diluted Continuous Ops | 2.27 | 1.79 | 0.43 | 2.00 | -0.12 |
EBITDA(a) | $7,053,000 | $6,433,000 | $6,641,000 | $6,318,000 | $5,818,000 |